COVID-19 Antibody Testing Kit For Australian Health Care Professionals

The APAC Security Australia COVID-19 Antibody Testing Kit can be offered to Health Care professionals only please register your interest to purchase Rapid Point of Care Test provides COVID-19 antibody screening results in 15 minutes. APAC Security Australia markets an IgM/IgG immunoassay screening device that measures the IgG and IgM response to SARS-CoV-2. The main benefit of this Device is to find out whether a person: Has been infected by SARS-CoV-2. Has an immunological IgG/IgM-response to SARS-CoV-2 either from; Infection Vaccination The answers to these two questions can be of significant benefit, for example aiding decisions around whether a person…

CLUNGENE COVID-19 IgG/IgM Rapid Test Cassette Point of Care testing

For Medical Practitioners only CLUNGENE COVID-19 IgG/IgM Rapid Test Cassette Point of Care testing APAC Security (APAC) markets an IgM/IgG immunoassay screening device that measures the IgG and IgM response to SARS-CoV-2. The main benefit of this Device is for post disease screening, finding out whether a person: Has been infected by SARS-CoV-2. Has an immunological IgG/IgM-response to SARS-CoV-2 The answers to these two questions can be of significant benefit, for example aiding decisions around whether a person can return to work, travel, or socialise with other people. This can be particularly pertinent in the decision making surrounding at-risk groups,…

COVID-19 IgG/IgM Rapid Test Cassette (WB/S/P)

For professional healthcare providers and in vitro diagnostic use only. [INTENDED USE] The COVID-19 IgG/IgM Rapid Test Cassette (Device) is a lateral flow immunoassay designed for the qualitative detection of IgG and IgM antibodies to the SARS-CoV-2 virus in whole blood, serum or plasma specimens. The Device provides an aid for identifying persons who may have been exposed to, and developed an immune response to the SARS- CoV-2 virus. [SUMMARY] SARS-CoV-2 is a new strain of coronavirus causing the disease COVID-19 in humans. The symptoms range from a mild respiratory infection to more severe pneumonia with acute respiratory distress. The…

Post-market validation of a further two serological assays for COVID-19

Updated Report

Post-market validation of a further two serological assays for COVID-19

_

13th October 2020 Report prepared for:

Office of Health Protection, Commonwealth Government of Australia The Therapeutics Goods Administration (TGA) of Australia

Report prepared by:

Dr Katherine Bond
Ms Suellen Nicholson
Ms Tuyet Hoang
Dr Mike Catton
Professor Benjamin Howden Professor Deborah Williamson

 

Clongene’s Rapid on-Site Test provides

FOR PROFESSIONAL USE ONLY Clongene’s Rapid on-Site Test provides COVID-19 screening results in 10 – 15 minutes SARS-CoV-2 is a new strain of coronavirus causing the disease COVID-19 in humans. The symptoms range from a mild respiratory infection to more severe pneumonia with acute respiratory distress. Contents Each Test kit includes: • Test Cassette, which holds the test strip where detection of the IgM and IgG antibodies take place • Lancet & alcohol pad • Dropper/Pipette • Buffer solution • IFU/Product insert Listed with TGA, TRIM Reference: E20-49236 The Australian Department of Health have decided to include the Clongene COVID-19…